RONALD HAUGEN: Open Payments
NPI 1356484448 · CARLSBAD, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$363 in 17 payments from 9 companies in 2025. Trend: 2023 $336 · 2024 $312 · 2025 $363
Food & beverage: $363
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 5 | $93 |
| ABBVIE INC. | 3 | $69 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 1 | $33 |
| Lundbeck LLC | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Indivior Inc. | 1 | $19 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
Products named: ARISTADA, VRAYLAR, REXULTI, Auvelity, COBENFY, CAPLYTA, SUBLOCADE, INGREZZA.
Industry payments across NM — which companies pay providers there.
